292 related articles for article (PubMed ID: 8717406)
41. Polarization of naive T cells into Th1 or Th2 by distinct cytokine-driven murine dendritic cell populations: implications for immunotherapy.
Feili-Hariri M; Falkner DH; Morel PA
J Leukoc Biol; 2005 Sep; 78(3):656-64. PubMed ID: 15961574
[TBL] [Abstract][Full Text] [Related]
42. T-cell cytokines affect mucosal immunoglobulin A transport.
Amin PB; Diebel LN; Liberati DM
Am J Surg; 2007 Jul; 194(1):128-33. PubMed ID: 17560924
[TBL] [Abstract][Full Text] [Related]
43. Optimizing oral vaccines: induction of systemic and mucosal B-cell and antibody responses to tetanus toxoid by use of cholera toxin as an adjuvant.
Jackson RJ; Fujihashi K; Xu-Amano J; Kiyono H; Elson CO; McGhee JR
Infect Immun; 1993 Oct; 61(10):4272-9. PubMed ID: 8406816
[TBL] [Abstract][Full Text] [Related]
44. Oral delivery of homologous and heterologous strains of rotavirus to BALB/c mice induces the same profile of cytokine production by spleen cells.
Fromantin C; Piroth L; Petitpas I; Pothier P; Kohli E
Virology; 1998 May; 244(2):252-60. PubMed ID: 9601496
[TBL] [Abstract][Full Text] [Related]
45. Expression of recombinant enterotoxigenic Escherichia coli colonization factor antigen I by Salmonella typhimurium elicits a biphasic T helper cell response.
Pascual DW; Hone DM; Hall S; van Ginkel FW; Yamamoto M; Walters N; Fujihashi K; Powell RJ; Wu S; Vancott JL; Kiyono H; McGhee JR
Infect Immun; 1999 Dec; 67(12):6249-56. PubMed ID: 10569734
[TBL] [Abstract][Full Text] [Related]
46. Peyer's patches are required for intestinal immunoglobulin A responses to Salmonella spp.
Hashizume T; Togawa A; Nochi T; Igarashi O; Kweon MN; Kiyono H; Yamamoto M
Infect Immun; 2008 Mar; 76(3):927-34. PubMed ID: 18086815
[TBL] [Abstract][Full Text] [Related]
47. Generalized systemic and mucosal immunity in mice after mucosal stimulation with cholera toxin.
Elson CO; Ealding W
J Immunol; 1984 Jun; 132(6):2736-41. PubMed ID: 6233359
[TBL] [Abstract][Full Text] [Related]
48. CD4+ subset expression in murine candidiasis. Th responses correlate directly with genetically determined susceptibility or vaccine-induced resistance.
Romani L; Mencacci A; Cenci E; Spaccapelo R; Mosci P; Puccetti P; Bistoni F
J Immunol; 1993 Feb; 150(3):925-31. PubMed ID: 8093707
[TBL] [Abstract][Full Text] [Related]
49. Interleukin 12 and innate molecules for enhanced mucosal immunity.
Boyaka PN; Lillard JW; McGhee J
Immunol Res; 1999; 20(3):207-17. PubMed ID: 10741861
[TBL] [Abstract][Full Text] [Related]
50. A nontoxic mutant of cholera toxin elicits Th2-type responses for enhanced mucosal immunity.
Yamamoto S; Kiyono H; Yamamoto M; Imaoka K; Fujihashi K; Van Ginkel FW; Noda M; Takeda Y; McGhee JR
Proc Natl Acad Sci U S A; 1997 May; 94(10):5267-72. PubMed ID: 9144226
[TBL] [Abstract][Full Text] [Related]
51. Interferon-gamma receptor-deficient mice exhibit impaired gut mucosal immune responses but intact oral tolerance.
Kjerrulf M; Grdic D; Ekman L; Schön K; Vajdy M; Lycke NY
Immunology; 1997 Sep; 92(1):60-8. PubMed ID: 9370925
[TBL] [Abstract][Full Text] [Related]
52. Toll-like receptor 5 is not essential for the promotion of secretory immunoglobulin A antibody responses to flagellated bacteria.
Hashizume-Takizawa T; Yamamoto M
Microbiol Immunol; 2015 Dec; 59(12):716-23. PubMed ID: 26564803
[TBL] [Abstract][Full Text] [Related]
53. Arginine enhances induction of T helper 1 and T helper 2 cytokine synthesis by Peyer's patch alpha beta T cells and antigen-specific mucosal immune response.
Kobayashi T; Yamamoto M; Hiroi T; McGhee J; Takeshita Y; Kiyono H
Biosci Biotechnol Biochem; 1998 Dec; 62(12):2334-40. PubMed ID: 9972259
[TBL] [Abstract][Full Text] [Related]
54. Requirements for B7-CD28 costimulation in mucosal IgA responses: paradoxes observed in CTLA4-H gamma 1 transgenic mice.
Gärdby E; Lane P; Lycke NY
J Immunol; 1998 Jul; 161(1):49-59. PubMed ID: 9647206
[TBL] [Abstract][Full Text] [Related]
55. Helper Th1 and Th2 cell responses following mucosal or systemic immunization with cholera toxin.
Xu-Amano J; Jackson RJ; Fujihashi K; Kiyono H; Staats HF; McGhee JR
Vaccine; 1994 Aug; 12(10):903-11. PubMed ID: 7975832
[TBL] [Abstract][Full Text] [Related]
56. Systemic and mucosal immune responses of mice to aluminium-adsorbed or aluminium-non-adsorbed tetanus toxoid administered intranasally with recombinant cholera toxin B subunit.
Isaka M; Yasuda Y; Kozuka S; Miura Y; Taniguchi T; Matano K; Goto N; Tochikubo K
Vaccine; 1998 Oct; 16(17):1620-6. PubMed ID: 9713937
[TBL] [Abstract][Full Text] [Related]
57. Oral immunization of mice with Saccharomyces cerevisiae expressing a neutralizing epitope of ApxIIA exotoxin from Actinobacillus pleuropneumoniae induces systemic and mucosal immune responses.
Shin MK; Lee WJ; Jung MH; Cha SB; Shin SW; Yoo A; Kim DH; Yoo HS
Microbiol Immunol; 2013 Jun; 57(6):417-25. PubMed ID: 23773020
[TBL] [Abstract][Full Text] [Related]
58. Distinct roles for Peyer's patch B cells for induction of antigen-specific IgA antibody responses in mice administered oral recombinant Salmonella.
Hashizume-Takizawa T; Shibata N; Kurashima Y; Kiyono H; Kurita-Ochiai T; Fujihashi K
Int Immunol; 2019 Jul; 31(8):531-541. PubMed ID: 30868152
[TBL] [Abstract][Full Text] [Related]
59. Development of a mucosal complex vaccine against oral Salmonella infection in mice.
Harada H; Nishikawa F; Higashi N; Kita E
Microbiol Immunol; 2002; 46(12):891-905. PubMed ID: 12597365
[TBL] [Abstract][Full Text] [Related]
60. Oral QS-21 requires early IL-4 help for induction of mucosal and systemic immunity.
Boyaka PN; Marinaro M; Jackson RJ; van Ginkel FW; Cormet-Boyaka E; Kirk KL; Kensil CR; McGhee JR
J Immunol; 2001 Feb; 166(4):2283-90. PubMed ID: 11160283
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
